Similarly, in a xenogenic model, direct intrarenal injection of human BM-MSCs was highly effective in treating LN in mice, achieving a 10-fold higher survival and decreasing renal expression of IL1β and IL17 [185]. This evidence concerns the gene IL17A and lobular neoplasia.